Skip to main content
Top
Published in: Inflammation 1/2012

01-02-2012

Genistein Inhibit Cytokines or Growth Factor-Induced Proliferation and Transformation Phenotype in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis

Authors: Yujun Zhang, Jianqiang Dong, Peiying He, Wende Li, Qi Zhang, Na Li, Tiezheng Sun

Published in: Inflammation | Issue 1/2012

Login to get access

Abstract

The purpose of this research is to study the effect of genistein on cytokines or growth factor-induced proliferation and transformation phenotype of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS). RA-FLS were primarily cultured. With respective stimulation of IL-1β, TNF-α, and EGF, genistein was applied to elucidate its effect on synoviocytes’ growth number, cell proliferation assay, cell cycle using cell counts, 3H-TdR incorporation and flow cytometry, the colony numbers under anchorage-independent condition, and the expression of MMP-2 and MMP-9 in synovial fibroblasts. EGF, IL-1β, and TNF-α increased 3H incorporation in RA-FLS, respectively. EGF augmented clone numbers of RA-FLS under anchorage-independent condition and not IL-1β and TNF-α. Genistein had an inhibitory role on cell number and 3H-TdR incorporation of RA-FLS stimulated with IL-1β, TNF-α and EGF; genistein arrested the cell cycle at G1 restriction point; genistein decreased colony numbers under anchorage-independent condition stimulated by EGF in serum condition. IL-1β or TNF-α increased expression of MMP-9 and MMP-2 in rheumatoid synoviocytes; EGF stimulated expression of MMP-9 but not of MMP-2; genistein suppressed production of MMP-9 more than MMP-2 induced by IL-1β or TNF-α; rMMP-9, rMMP-2, or their inhibitors had no effect on the 3H-TdR incorporation of synovial cells. Erk1/2 inhibitor (PD098 059) had obvious inhibitory effect on the 3H incorporation induced by TNF-α or IL-1β; inhibitors of JNK (SP600 125) had no significant effect on the 3H incorporation. While pretreatment with PD098059 had no marked inhibitory effect on MMP-9 expression induced by TNF-α or IL-1β, SP600125 decreased significantly the MMP-9 expression induced by TNF-α or IL-1β. Neither PD098059 nor SP600 125 could inhibit the MMP-2 expression induced by TNF-α or IL-1β. Genistein inhibited IL-1β, TNF-α or EGF-induced proliferation and MMP-9 expression in fibroblast-like synoviocytes of rheumatoid arthritis; the proliferation of RA-FLS was mediated by Erk1/2 but not JNK activation, while JNK activation was involved in the signal transduction pathway leading to MMP-9 expression in rheumatoid synoviocytes.
Literature
2.
go back to reference Remmers, E.F., R. Lafyatis, G.K. Kumkumian, et al. 1990. Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Grow Factors 2: 179–188. Remmers, E.F., R. Lafyatis, G.K. Kumkumian, et al. 1990. Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Grow Factors 2: 179–188.
3.
go back to reference Lafyatis, R., E.F. Remmers, A.B. Roberts, et al. 1989. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. The Journal of Clinical Investigation 83: 1267–1276.PubMedCrossRef Lafyatis, R., E.F. Remmers, A.B. Roberts, et al. 1989. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. The Journal of Clinical Investigation 83: 1267–1276.PubMedCrossRef
4.
go back to reference Qu, Z., C.H. Garcia, L.M. O’Rourke, S.R. Planck, M. Kohli, and J.T. Rosenbaum. 1994. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia: Results of proliferating cell nuclear antigen, cyclin, c-myc, and nucleolar organizer region staining. Arthritis and Rheumatism 37: 212–220.PubMedCrossRef Qu, Z., C.H. Garcia, L.M. O’Rourke, S.R. Planck, M. Kohli, and J.T. Rosenbaum. 1994. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia: Results of proliferating cell nuclear antigen, cyclin, c-myc, and nucleolar organizer region staining. Arthritis and Rheumatism 37: 212–220.PubMedCrossRef
5.
go back to reference Müller-Ladner, U., J. Kriegsmann, R.E. Gay, and S. Gay. 1995. Oncogenes in rheumatoid arthritis. Rheumatic Diseases Clinics of North America 21: 675–690.PubMed Müller-Ladner, U., J. Kriegsmann, R.E. Gay, and S. Gay. 1995. Oncogenes in rheumatoid arthritis. Rheumatic Diseases Clinics of North America 21: 675–690.PubMed
6.
go back to reference Firestein, G.S., K. Nguyen, K.R. Aupperle, M. Yeo, D.L. Boyle, and N.J. Zvaifler. 1996. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. American Journal of Pathology 149: 2143–2151.PubMed Firestein, G.S., K. Nguyen, K.R. Aupperle, M. Yeo, D.L. Boyle, and N.J. Zvaifler. 1996. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. American Journal of Pathology 149: 2143–2151.PubMed
7.
go back to reference Muller-Ladner, U., J. Kriegsmann, B.N. Franklin, S. Matsomoto, T. Geiler, R.E. Gay, et al. 1996. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. American Journal of Pathology 49: 1607–1615. Muller-Ladner, U., J. Kriegsmann, B.N. Franklin, S. Matsomoto, T. Geiler, R.E. Gay, et al. 1996. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. American Journal of Pathology 49: 1607–1615.
8.
go back to reference Pap, T., I. Meinecke, U. Muller-Ladner, and S. Gay. 2005. Are fibroblasts involved in joint destruction? Annals of the Rheumatic Diseases 64(Suppl. 4): iv52–iv54.PubMedCrossRef Pap, T., I. Meinecke, U. Muller-Ladner, and S. Gay. 2005. Are fibroblasts involved in joint destruction? Annals of the Rheumatic Diseases 64(Suppl. 4): iv52–iv54.PubMedCrossRef
9.
go back to reference Tanos, V., A. Brzezinski, O. Drize, N. Strauss, and T. Peretz. 2002. Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. European Journal of Obstetrics, Gynecology, and Reproductive Biology 102(2): 188–194.PubMedCrossRef Tanos, V., A. Brzezinski, O. Drize, N. Strauss, and T. Peretz. 2002. Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. European Journal of Obstetrics, Gynecology, and Reproductive Biology 102(2): 188–194.PubMedCrossRef
10.
go back to reference Fotsis, T., M.S. Pepper, E. Aktas, S. Breit, S. Rasku, H. Adlercreutz, K. Wahala, R. Montesano, and L. Schweigerer. 1997. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Research 57: 2916–2921.PubMed Fotsis, T., M.S. Pepper, E. Aktas, S. Breit, S. Rasku, H. Adlercreutz, K. Wahala, R. Montesano, and L. Schweigerer. 1997. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Research 57: 2916–2921.PubMed
11.
go back to reference Lamartiniere, C.A. 2000. Protection against breast cancer with genistein: A component of soy. American Journal of Clinical Nutrition 71: 1708S–1709S. Lamartiniere, C.A. 2000. Protection against breast cancer with genistein: A component of soy. American Journal of Clinical Nutrition 71: 1708S–1709S.
12.
go back to reference Arnet, F.C., S.M. Edworthy, D.A. Bloch, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 3152–3241. Arnet, F.C., S.M. Edworthy, D.A. Bloch, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 3152–3241.
13.
go back to reference James, W.P. 2008. The fundamental drivers of the obesity epidemic. Obesity Reviews 9(Suppl. 1): 6–13.PubMedCrossRef James, W.P. 2008. The fundamental drivers of the obesity epidemic. Obesity Reviews 9(Suppl. 1): 6–13.PubMedCrossRef
14.
go back to reference Magee, P.J., and I.R. Rowland. 2004. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. British Journal of Nutrition 91: 513–531.PubMedCrossRef Magee, P.J., and I.R. Rowland. 2004. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. British Journal of Nutrition 91: 513–531.PubMedCrossRef
15.
go back to reference Lamartiniere, C.A. 2000. Protection against breast cancer with genistein: a component of soy. American Journal of Clinical Nutrition 71: 1705S–1707S.PubMed Lamartiniere, C.A. 2000. Protection against breast cancer with genistein: a component of soy. American Journal of Clinical Nutrition 71: 1705S–1707S.PubMed
16.
go back to reference Cappelletti, V., L. Fioravanti, P. Miodini, and G. Di Fronzo. 2000. Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. Journal of Cellular Biochemistry 79(4): 594–600.PubMedCrossRef Cappelletti, V., L. Fioravanti, P. Miodini, and G. Di Fronzo. 2000. Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. Journal of Cellular Biochemistry 79(4): 594–600.PubMedCrossRef
17.
go back to reference Lu, H., T. Sun, L. Yao, and Y. Zhang. 2000. Role of protein tyrosine kinase in IL-1β induced activation of mitogen- activated protein kinase in fibroblast-like synoviocytes of rheumatoid arthritis. Chinese Medical Journal 113(10): 872–876.PubMed Lu, H., T. Sun, L. Yao, and Y. Zhang. 2000. Role of protein tyrosine kinase in IL-1β induced activation of mitogen- activated protein kinase in fibroblast-like synoviocytes of rheumatoid arthritis. Chinese Medical Journal 113(10): 872–876.PubMed
18.
go back to reference Charoenrat, P., H. Modjtahedi, P. Rhys-Evans, W. Court, G. Box, and S. Eccles. 2000. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Research 60: 1121–1128. Charoenrat, P., H. Modjtahedi, P. Rhys-Evans, W. Court, G. Box, and S. Eccles. 2000. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Research 60: 1121–1128.
19.
go back to reference Liu, Z., and J. Klominek. 2003. Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors. Thorax 58: 198–203.PubMedCrossRef Liu, Z., and J. Klominek. 2003. Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors. Thorax 58: 198–203.PubMedCrossRef
20.
go back to reference Nutt, J., G. Durkan, J. Mellon, and J. Lunec. 2003. Matrix metalloproteinases (MMPs) in bladder cancer: The induction of MMP9 by epidermal growth factor and its detection in urine. BJU International 91: 99–104.PubMedCrossRef Nutt, J., G. Durkan, J. Mellon, and J. Lunec. 2003. Matrix metalloproteinases (MMPs) in bladder cancer: The induction of MMP9 by epidermal growth factor and its detection in urine. BJU International 91: 99–104.PubMedCrossRef
21.
go back to reference Gonzalez, R., L. Devoto, A. Campana, and P. Bischof. 2001. Effects of leptin, interleukin-1alpha, interleukin-6, and transforming growth factor-beta on markers of trophoblast invasive phenotype: integrins and metalloproteinases. Endocrine 15: 157–164.PubMedCrossRef Gonzalez, R., L. Devoto, A. Campana, and P. Bischof. 2001. Effects of leptin, interleukin-1alpha, interleukin-6, and transforming growth factor-beta on markers of trophoblast invasive phenotype: integrins and metalloproteinases. Endocrine 15: 157–164.PubMedCrossRef
22.
go back to reference Bischof, P., K. Truong, and A. Campana. 2003. Regulation of trophoblastic gelatinases by proto-oncogenes. Placenta 24: 155–163.PubMedCrossRef Bischof, P., K. Truong, and A. Campana. 2003. Regulation of trophoblastic gelatinases by proto-oncogenes. Placenta 24: 155–163.PubMedCrossRef
23.
go back to reference Unemori, E.N., M.S. Hibbs, and E.P. Amento. 1991. Constitutive expression of a 92KD gelantinase (type V collagenase) by rheumatoid synovial fibroblast and its induction in normal human fibroblasts by inflammatory cytokines. The Journal of Clinical Investigation 88: 1656–1662.PubMedCrossRef Unemori, E.N., M.S. Hibbs, and E.P. Amento. 1991. Constitutive expression of a 92KD gelantinase (type V collagenase) by rheumatoid synovial fibroblast and its induction in normal human fibroblasts by inflammatory cytokines. The Journal of Clinical Investigation 88: 1656–1662.PubMedCrossRef
24.
go back to reference Sheu, B.C., S.M. Hsu, H.N. Ho, H.C. Lien, S.C. Huang, and R.H. Lin. 2001. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Research 61: 237–242.PubMed Sheu, B.C., S.M. Hsu, H.N. Ho, H.C. Lien, S.C. Huang, and R.H. Lin. 2001. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Research 61: 237–242.PubMed
25.
go back to reference Hartland, S.N., F. Murphy, R.L. Aucott, et al. 2009. Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. Liver International 29: 966–978.PubMedCrossRef Hartland, S.N., F. Murphy, R.L. Aucott, et al. 2009. Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. Liver International 29: 966–978.PubMedCrossRef
26.
go back to reference Wielockx, B., K. Lannoy, S.D. Shapiro, et al. 2001. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nature Medicine 7: 1202–1208.PubMedCrossRef Wielockx, B., K. Lannoy, S.D. Shapiro, et al. 2001. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nature Medicine 7: 1202–1208.PubMedCrossRef
27.
go back to reference Sato, H., and M. Seiki. 1993. Regulatory mechanism of 92-kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395–405.PubMed Sato, H., and M. Seiki. 1993. Regulatory mechanism of 92-kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395–405.PubMed
28.
go back to reference Wiehler, S., S.L. Cuvelier, S. Chakrabarti, and K.D. Patel. 2004. p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils. Biochemical and Biophysical Research Communications 315: 463–470.PubMedCrossRef Wiehler, S., S.L. Cuvelier, S. Chakrabarti, and K.D. Patel. 2004. p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils. Biochemical and Biophysical Research Communications 315: 463–470.PubMedCrossRef
29.
go back to reference Holvoet, S., C. Vincent, D. Schmitt, and M. Serres. 2003. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Experimental Cell Research 290: 108–119.PubMedCrossRef Holvoet, S., C. Vincent, D. Schmitt, and M. Serres. 2003. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Experimental Cell Research 290: 108–119.PubMedCrossRef
30.
go back to reference Han, Z., D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, et al. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. The Journal of Clinical Investigation 108: 73–81.PubMed Han, Z., D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, et al. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. The Journal of Clinical Investigation 108: 73–81.PubMed
31.
go back to reference Schultze-Mosgau, M.H., I.L. Dale, T.W. Gant, J.K. Chipman, D.J. Kerr, and A. Gescher. 1998. Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. European Journal of Cancer 34(9): 1425–1431.PubMedCrossRef Schultze-Mosgau, M.H., I.L. Dale, T.W. Gant, J.K. Chipman, D.J. Kerr, and A. Gescher. 1998. Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. European Journal of Cancer 34(9): 1425–1431.PubMedCrossRef
32.
go back to reference Huang, S., M. Koneiczkowski, and J.R. Sedor. 1994. Redox regulation of cytosolic tyrosine kinases by IL-1α(Abstract). Journal of the American Society of Nephrology 5: 716. Huang, S., M. Koneiczkowski, and J.R. Sedor. 1994. Redox regulation of cytosolic tyrosine kinases by IL-1α(Abstract). Journal of the American Society of Nephrology 5: 716.
Metadata
Title
Genistein Inhibit Cytokines or Growth Factor-Induced Proliferation and Transformation Phenotype in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis
Authors
Yujun Zhang
Jianqiang Dong
Peiying He
Wende Li
Qi Zhang
Na Li
Tiezheng Sun
Publication date
01-02-2012
Publisher
Springer US
Published in
Inflammation / Issue 1/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9365-x

Other articles of this Issue 1/2012

Inflammation 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.